logo

For the Inventor, By the Inventor

Alameda, CA, United States of America

Therasense, Inc.


USPTO Granted Patents = 53

% Expired Patents = 3.8



Trademarks = 3

Forward Citations = 46,901

Loading Chart...
Loading Chart...

60 inventors (with patents filed for the assignee):

goldMedal Adam Heller (37 out of 276 patents)

silverMedal James L Say (13 out of 121 patents)

bronzeMedal Fei Mao (11 out of 136 patents)

4.  Ephraim Heller (11 out of 126 patents)

5.  Mark S Vreeke (11 out of 92 patents)

6.  Benjamin J Feldman (11 out of 250 patents)

7.  Fredric C Colman (10 out of 114 patents)

8.  Joseph A Vivolo (9 out of 57 patents)

9.  Phillip John Plante (8 out of 75 patents)

10.  Michael F Tomasco (8 out of 97 patents)

11.  Jeffery Van Funderburk (8 out of 95 patents)

12.  Rajesh Krishnan (7 out of 44 patents)

13.  Behrad Aria (6 out of 78 patents)

14.  Yoram Gal (6 out of 75 patents)

15.  Keith A Friedman (4 out of 51 patents)


Core Competencies:
Electrochemical Sensors
Glucose Monitoring
Analyte Detection
Biosensor
Transition Metal Complexes
Lancing Device
Blood Glucose Tracking
In Vitro Sensors
Redox Mediators
Biological Fuel Cell
Potentiometric Sensors
Electrodeposition

53 patents:

1. 7545272 - RF tag on test strips, test strip vials and boxes (2009-06-09),
2. 7090756 - Transition metal complexes with bidentate ligand having an imidazole ring (2006-08-15),
3. 7074308 - Transition metal complexes with (pyridyl)imidazole ligands (2006-07-11),
4. 7058437 - Methods of determining concentration of glucose (2006-06-06),
5. 7052591 - Electrodeposition of redox polymers and co-electrodeposition of enzymes by coordinative crosslinking (2006-05-30),
6. 7041468 - Blood glucose tracking apparatus and methods (2006-05-09),
7. 7005273 - Method for the determination of glycated hemoglobin (2006-02-28),
8. 6990366 - Analyte monitoring device and methods of use (2006-01-24),
9. 6975893 - Mass transport limited in vivo analyte sensor (2005-12-13),
10. 6973706 - Method of making a transcutaneous electrochemical sensor (2005-12-13),
11. 6942518 - Small volume in vitro analyte sensor and methods (2005-09-13),
12. 6932894 - Biosensor membranes composed of polymers containing heterocyclic nitrogens (2005-08-23),
13. 6916159 - Device and method employing shape memory alloy (2005-07-12),
14. 6893545 - Biosensor (2005-05-17),
15. 6881551 - Subcutaneous glucose electrode (2005-04-19),
Therasense, Inc., based in Alameda, CA, specializes in the development of advanced electrochemical sensors, primarily for glucose monitoring and analyte detection. The company focuses on innovative biosensor technologies, including lancing devices and blood glucose tracking systems, aimed at improving diabetes management. By leveraging expertise in transition metal complexes and in vitro sensors, Therasense is committed to enhancing the accuracy and reliability of glucose measurement, contributing to better health outcomes for individuals with diabetes.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

53 Patents

#12 in Alameda, CA

#1,566 in California

#6,664 in US

#13,323 in the World

Alameda, CA (US)
Alameda, CA, United States of America

Therasense, Inc.

Forward Citations = 46,901

60 inventors:

goldMedal Adam Heller (37 out of 276 patents)

silverMedal James L Say (13 out of 121 patents)

bronzeMedal Fei Mao (11 out of 136 patents)

4.  Ephraim Heller (11 out of 126 patents)

5.  Mark S Vreeke (11 out of 92 patents)

Please report any incorrect information to [email protected]
Loading…